Page last updated: 2024-10-23

bisoprolol and Arrhythmogenic Right Ventricular Cardiomyopathy

bisoprolol has been researched along with Arrhythmogenic Right Ventricular Cardiomyopathy in 2 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
" Before pregnancy, she was treated with bisoprolol, which resulted in a reduction in extrasystoles and she never developed palpitations."3.80Successful obstetric management of arrhythmogenic right ventricular cardiomyopathy. ( Carpinella, G; Corioni, S; Cozzolino, M; Mecacci, F; Perelli, F, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tanaka, TD1
Suzuki, T1
Marcus, FI1
Cozzolino, M1
Perelli, F1
Corioni, S1
Carpinella, G1
Mecacci, F1

Other Studies

2 other studies available for bisoprolol and Arrhythmogenic Right Ventricular Cardiomyopathy

ArticleYear
Sustained Wide Complex Tachycardia in a Healthy Man.
    JAMA internal medicine, 2021, 10-01, Volume: 181, Issue:10

    Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Bisoprolol; Defibrillator

2021
Successful obstetric management of arrhythmogenic right ventricular cardiomyopathy.
    Gynecologic and obstetric investigation, 2014, Volume: 78, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Bisoprolo

2014